The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

  • This share is currently suspended. It was suspended at a price of 5.375

Share Price Information for Iconic Labs (ICON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.375
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.375
ICON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partnership with leading Ad-tech tech provider

30 Sep 2020 08:30

RNS Number : 4966A
Iconic Labs PLC
30 September 2020
 

 

 

 

 

Iconic Labs Plc ("Iconic Labs" or the "Company")

 

Partnership with leading Ad-tech tech provider

 

Iconic Labs Plc (LSE:ICON), a multidivisional new media and technology business, today announces that after a successful trial Iconic Labs has signed a commercial partnership agreement with Glimpse Protocol, a leading provider of advanced technologies to Ad-tech.

This partnership will allow Iconic Labs to be well positioned to become industry leaders in the cookieless advertising space and future proof this part of the Company's business. Glimpse Protocol will benefit from Iconic Labs advertising experience and access to multiple platforms, including to trial their technology.

Glimpse Protocol will compete for programmatic inventory on the Iconic Labs platforms with other advertisers and will not receive any discount to market rate. This offering will allow programmatic advertisers to comply with GDPR and internal policies while still conducting effective advertising.

Iconic Labs will use the Glimpse Protocol's technology on all of their owned and operated platforms including JOE Media where the Glimpse Protocol platform will be tested and monitored in real time. The Glimpse Protocol platform is currently live on TLE, protecting 1.5million readers so far from their browsing information being obtained by other parties.

In addition to the operational benefits that it provides, it has been agreed that warrants will be issued to Iconic Labs in recognition of their market access and wider advisory support. The warrants entitle Iconic Labs to subscribe for such number of ordinary shares in the capital of Glimpse Protocol, which shall be equal to 1.25% of its issued equity and which are exercisable at a discount to the subscription price payable for ordinary shares on any future sale or capital raise undertaken by Glimpse Protocol.

Glimpse Protocol are a market leader in data protection using frontier technologies. Their cookieless platform uses two forms of advanced cryptography to protect consumers' personal internet browsing data from being seen, read, transferred, sold or recycled by another party.

Google have recently announced within 2 years their chrome browser will no longer be using cookies which store personal browsing data on your PC/Phone. Apple have also taken a similar approach with their safari browser.

Samuel Regan Asante COO of Iconic Labs - "We are very pleased to announce a partnership with Glimpse Protocol who are leading the way in cookie-less technologies within the AdTech industry. Iconic Labs is aiming to establish itself as a leader in both the tech and media fields and Glimpse Protocol's technology presents the perfect balance of the two. With Glimpse Protocol's existing partnership with The Founder's Factory we're excited about their future as a leader in the industry."

 

 

 

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

**ENDS**

For further information, please visit the Company's website www.iconiclabs.co.uk or contact:

Damon Heath

Shard Capital Partners LLP

Tel: +44 (0) 20 7186 9950

Iconic Labs ir@iconiclabs.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRUKONRROUKUAR
Date   Source Headline
19th May 20214:00 pmRNSDirectorate Change
10th May 202111:05 amRNSSecond Price Monitoring Extn
10th May 202111:00 amRNSPrice Monitoring Extension
10th May 20219:05 amRNSSecond Price Monitoring Extn
10th May 20219:00 amRNSPrice Monitoring Extension
10th May 20218:12 amRNSLetter of Intent Signed : Sting Industries
4th May 20214:41 pmRNSSecond Price Monitoring Extn
4th May 20214:36 pmRNSPrice Monitoring Extension
4th May 20212:06 pmRNSSecond Price Monitoring Extn
4th May 20212:01 pmRNSPrice Monitoring Extension
30th Apr 20214:41 pmRNSSecond Price Monitoring Extn
30th Apr 20214:35 pmRNSPrice Monitoring Extension
30th Apr 20212:17 pmRNSHalf-year Report
29th Apr 20217:52 amRNSDirectorate Change
23rd Apr 202111:05 amRNSSecond Price Monitoring Extn
23rd Apr 202111:00 amRNSPrice Monitoring Extension
21st Apr 20214:35 pmRNSPrice Monitoring Extension
19th Apr 20212:06 pmRNSSecond Price Monitoring Extn
19th Apr 20212:01 pmRNSPrice Monitoring Extension
16th Apr 202111:06 amRNSSecond Price Monitoring Extn
16th Apr 202111:00 amRNSPrice Monitoring Extension
16th Apr 20219:03 amRNSEHGOF withdraws its claims
14th Apr 20217:00 amRNSStatement re Dispute with Greencastle
1st Apr 202111:00 amRNSPrice Monitoring Extension
26th Mar 20214:40 pmRNSSecond Price Monitoring Extn
26th Mar 20214:36 pmRNSPrice Monitoring Extension
26th Mar 20214:01 pmRNSAgreement
26th Mar 20217:00 amRNSDirectorate Change
23rd Mar 20219:05 amRNSSecond Price Monitoring Extn
23rd Mar 20219:00 amRNSPrice Monitoring Extension
23rd Mar 20217:00 amRNSDirectorate Change
22nd Mar 20212:06 pmRNSSecond Price Monitoring Extn
22nd Mar 20212:01 pmRNSPrice Monitoring Extension
19th Mar 20217:00 amRNSDirectorate Change
8th Mar 20214:41 pmRNSSecond Price Monitoring Extn
8th Mar 20214:36 pmRNSPrice Monitoring Extension
5th Mar 20219:05 amRNSSecond Price Monitoring Extn
5th Mar 20219:00 amRNSPrice Monitoring Extension
3rd Mar 20212:05 pmRNSSecond Price Monitoring Extn
3rd Mar 20212:00 pmRNSPrice Monitoring Extension
3rd Mar 202110:50 amRNSDirectorate Change
19th Feb 202111:00 amRNSPrice Monitoring Extension
12th Feb 20213:13 pmRNSDirectorate Change
9th Feb 20217:00 amRNSDirectorate Change
8th Feb 20219:05 amRNSSecond Price Monitoring Extn
8th Feb 20219:00 amRNSPrice Monitoring Extension
5th Feb 202111:06 amRNSSecond Price Monitoring Extn
5th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20219:05 amRNSSecond Price Monitoring Extn
5th Feb 20219:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.